PREVent-COVID Extension Study
A Prospective study Evaluating COVID-19 Vaccine immunogenicity in Organ Transplant Recipients (the PREVenT-COVID study) Extension– Pediatric Arm
Project Summary
Children who received organ transplant are eligible to receive COVID-19 vaccine when it is licensed for their age group. People with organ transplant may have different immune response to COVID-19 vaccine compared to their “healthy” peers. This is the extension of the PREVenT-COVID study. We will assess immune response to COVID-19 vaccine in BC children living with organ transplant 2 years following their first vaccination to better understand long-term immunity.
This project is supported by the Transplant Research Foundation of British Columbia and Big Gifts for Little Lives Alberta.
Status: Active, data collection ongoing
Study Start Date: April 8, 2022
Study End Date: December 31, 2024
Study Enrolment Status: Closed
Start Date: Oct 1, 2022
End Date: July 24, 2023
Principal Investigator
Co-investigators
- Catherine Burton, Assistant Professor, Department of Pediatrics, University of Alberta
- Sneha Suresh, Associate Professor, Department of Pediatrics, University of Alberta
- Manish Sadarangani, Associate Professor, Department of Pediatrics, Faculty of Medicine, University of British Columbia
- Tom Blydt-Hansen, Associate Professor, Department of Pediatrics, Faculty of Medicine, University of British Columbia
Research Team Members
- Candice Wiedman, Research Assistant
- Kimia Navirian, Research Assistant
- Monica Ho, Research Coordinator
- Have been enrolled in PREVent-COVID study
- At BCCH, potential participants who are SOT recipients must also have previously consented to the BCCH Biobanking Registry (H17-06240) in order to be eligible OR are willing to consent into the BCCH Biobanking Registry at the time of enrolling into this current study.
- At BCCH, potential participants have to be able to come to BCCH for all the study-related blood draws
For more information, please email Candice.Wiedman@bcchr.ca.
